Dr Kirk Barber speaks with Dr Sheetal Sapra, a dermatologist and co-founder of the Institute of Cosmetic and Laser Surgery in Oakville Ontario, about the study he co-authored examining the effectiveness, safety, and patient satisfaction of daylight-mediated methyl 5-aminolevulinate (MAL)–PDT. Dr Sapra also shares his clinical experience using this treatment and his approach to managing patient concerns and expectations.
Dr Kirk Barber speaks with Dr Jensen Yeung a dermatologist at the University of Toronto and the medical director of PERC, the Phototherapy Education and Research Centre at Women’s College Hospital in Toronto about the study he co-authored that examines the efficacy and safety of Apremilast monotherapy for moderate to severe Psoriasis. He also offers valuable insights into his use clinical use of apremilast outlining the risks and benefits from the perspective of a clinician.
Dr. Neil Shear, Professor of Medicine ( Dermatology), and Pharmacology (clinical pharmacology and toxicology) at the University of Toronto and the current President of the Canadian Dermatology Association is one of the authors of the manuscript titled “Toxic Epidermal Necrolysis Spectrum Management At Sunnybrook Health Sciences Centre : Our Multidisciplinary Approach After Review Of The Current Evidence” published in our March\April 2018 issue, Volume 22, Number 2 .
Doctor Shear and his...
JCMS editor-in-chief Dr. Kirk Barber speaks with Dr. Mark Kirchhof, co-author of a study that summarizes the research on the medicinal uses of cannabis in the dermatology clinic and some of the side effects that might present more often to dermatologists as the use of cannabis increases. In this conversation, they review the key points from the study and look ahead to areas in need of future research.